{"schema_version":"secwatch.filing_event.v1","accession":"0000875045-26-000003","form_type":"8-K","ticker":"BIIB","cik":"0000875045","company_name":"BIOGEN INC.","filed_at":"2026-01-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.876289+00:00","generated_at":"2026-05-16T10:32:11.149524+00:00","sec_items":["2.02"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Biogen expects ~$222M pre-tax charge in Q4 2025 for IPR&D and milestone costs; EPS impact ~$1.26","bullets":["Q4 2025 acquired IPR&D, upfront and milestone expense estimated at ~$222M pre-tax.","Estimated impact of $1.26 per diluted share on both GAAP and non-GAAP EPS.","Expense line item newly presented separately since Q1 2025.","Final Q4 2025 results not finalized; subject to closing procedures.","Company does not forecast such expenses due to uncertainty in timing and magnitude."],"urls":{"canonical":"https://secwatch.observer/filing/0000875045-26-000003","json":"https://secwatch.observer/filing/0000875045-26-000003.json","markdown":"https://secwatch.observer/filing/0000875045-26-000003.md","text":"https://secwatch.observer/filing/0000875045-26-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000003/0000875045-26-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000003/biib-20260113.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:32:11.149524+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}